# Moxonidine Effects on Neuropeptide Y

> **NCT05147753** · PHASE4 · COMPLETED · sponsor: **Aristotle University Of Thessaloniki** · enrollment: 90 (actual)

## Conditions studied

- Obesity
- Hypertension

## Interventions

- **DRUG:** Moxonidine

## Key facts

- **NCT ID:** NCT05147753
- **Lead sponsor:** Aristotle University Of Thessaloniki
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01-11
- **Primary completion:** 2014-06-30
- **Final completion:** 2014-06-30
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2021-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05147753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05147753, "Moxonidine Effects on Neuropeptide Y". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05147753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*